Daniel V. Ebner

7.6k citations
91 papers · 5.1k · 4 hit papers · h-index 30

Impact in

Papers in

    • SARS-CoV-2 and COVID-19 Research 13
    • COVID-19 Clinical Research Studies 6
    • SARS-CoV-2 detection and testing 4
    • CRISPR and Genetic Engineering 9
    • DNA Repair Mechanisms 5
    • Pluripotent Stem Cells Research 5
    • Molecular Biology Techniques and Applications 5

Daniel V. Ebner

85 papers receiving 4.9k citations

Daniel V. Ebner's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+3+6Years since publication100200300400

Peers

Daniel V. Ebner
Comparison fields: 5 of 147
  • Infectious Diseases 2.2k
  • Modeling and Simulation 313
  • Immunology and Allergy 202
  • Health 184
  • Neurology 317
Replace Nathan Richoz with:
Nathan Richoz United Kingdom
Ni Tang China
Benjamin J. Dunmore United Kingdom
James E. D. Thaventhiran United Kingdom
Beibei Wang China
Rose K. Davidson United Kingdom
Nathalie Kingston United Kingdom
Sebastian R. Schulz Germany
Bo-Wen Zhang China
Carmen Treacy United Kingdom
Daniel V. Ebner relative to Nathan Richoz United Kingdom Nathan Richoz's profile →
Citations per field
00.5×10×20×30×40×46.3×
Nathan Richoz · 1×
Citations per year

Countries citing papers authored by Daniel V. Ebner

Since Specialization
Citations

This map shows the geographic impact of Daniel V. Ebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel V. Ebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel V. Ebner more than expected).

Fields of papers citing papers by Daniel V. Ebner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel V. Ebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel V. Ebner. The network helps show where Daniel V. Ebner may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel V. Ebner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel V. Ebner Line = papers co-authored together Daniel V. Ebner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020649
2
Screening out irrelevant cell-based models of disease
Hit paper breakdown →
2016426
3
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
4
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
5 2020281
6 2021226
7 2013218
8 2021214
9 2019203
10 2020194
11 2021163
12
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Hit paper breakdown →
2022158
13 2019157
14 2016125
15 202189
16 202184
17 201671
18 202168
19 202160
20 202054

About Daniel V. Ebner

Daniel V. Ebner is a scholar working on Infectious Diseases, Molecular Biology, Oncology, Cancer Research and Physiology, having authored 91 papers that have together received 5.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), CRISPR and Genetic Engineering (9 papers), COVID-19 Clinical Research Studies (6 papers), DNA Repair Mechanisms (5 papers), Pluripotent Stem Cells Research (5 papers), Molecular Biology Techniques and Applications (5 papers), SARS-CoV-2 detection and testing (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Modeling and Simulation (313 citations), Immunology and Allergy (202 citations), Health (184 citations) and Neurology (317 citations). Daniel V. Ebner has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Neil O. Carragher, Marc Bickle, Carina von Schantz, Elaine Del Nery, Péter Horváth, Päivi Östling, Leo Price, Nathalie Aulner, Spencer L. Shorte and Vilja Pietiäinen. Their work appears in journals such as Nature Communications, Oncotarget, Scientific Reports, Clinical Infectious Diseases and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact